Browse > Article
http://dx.doi.org/10.4062/biomolther.2019.202

Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers  

Kandeel, Mahmoud (Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University)
Yamamoto, Mizuki (Research Center for Asian Infectious Diseases, Institute of Medical Science, The University of Tokyo)
Al-Taher, Abdulla (Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University)
Watanabe, Aya (Division of Cellular and Molecular Biology, Department of Cancer Biology, Institute of Medical Science, The University of Tokyo)
Oh-hashi, Kentaro (Department of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University)
Park, Byoung Kwon (Department of Microbiology, Hallym University College of Medicine)
Kwon, Hyung-Joo (Department of Microbiology, Hallym University College of Medicine)
Inoue, Jun-ichiro (Research Center for Asian Infectious Diseases, Institute of Medical Science, The University of Tokyo)
Al-Nazawi, Mohammed (Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University)
Publication Information
Biomolecules & Therapeutics / v.28, no.4, 2020 , pp. 311-319 More about this Journal
Abstract
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a newly emerging viral disease with fatal outcomes. However, no MERS-CoV-specific treatment is commercially available. Given the absence of previous structure-based drug discovery studies targeting MERS-CoV fusion proteins, this set of compounds is considered the first generation of MERS-CoV small molecule fusion inhibitors. After a virtual screening campaign of 1.56 million compounds followed by cell-cell fusion assay and MERS-CoV plaques inhibition assay, three new compounds were identified. Compound numbers 22, 73, and 74 showed IC50 values of 12.6, 21.8, and 11.12 µM, respectively, and were most effective at the onset of spike-receptor interactions. The compounds exhibited safe profiles against Human embryonic kidney cells 293 at a concentration of 20 µM with no observed toxicity in Vero cells at 10 µM. The experimental results are accompanied with predicted favorable pharmacokinetic descriptors and drug-likeness parameters. In conclusion, this study provides the first generation of MERS-CoV fusion inhibitors with potencies in the low micromolar range.
Keywords
MERS-CoV; Antiviral agents; Virtual screening; Plaques inhibition;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Park, B. K., Maharjan, S., Lee, S. I., Kim, J., Bae, J. Y., Park, M. S. and Kwon, H. J. (2019) Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex. BMB Rep. 52, 397-402.   DOI
2 Rahman, A. and Sarkar, A. (2019) Risk factors for fatal Middle East respiratory syndrome coronavirus infections in Saudi Arabia: analysis of the WHO line list, 2013-2018. Am. J. Public Health 109, 1288-1293.   DOI
3 Rahman, M. M., Hosen, M. B., Howlader, M. Z. H. and Kabir, Y. (2019) Lead molecule prediction and characterization for designing MERS-CoV 3C-like protease inhibitors: an in silico approach. Curr. Comput. Aided Drug Des. 15, 82-88.
4 Shen, L., Niu, J., Wang, C., Huang, B., Wang, W., Zhu, N., Deng, Y., Wang, H., Ye, F., Cen, S. and Tan, W. (2019) High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J. Virol. 93, e00023-19.
5 Su, S., Wong, G., Liu, Y., Gao, G. F., Li, S. and Bi, Y. (2015) MERS in South Korea and China: a potential outbreak threat? Lancet 385, 2349-2350.   DOI
6 Memish, Z. A., Zumla, A. I., Al-Hakeem, R. F., Al-Rabeeah, A. A. and Stephens, G. M. (2013) Family cluster of Middle East respiratory syndrome coronavirus infections. N. Engl. J. Med. 368, 2487-2494.   DOI
7 Oh-hashi, K., Soga, A., Naruse, Y., Takahashi, K., Kiuchi, K. and Hirata, Y. (2018) Elucidating post-translational regulation of mouse CREB3 in Neuro2a cells. Mol. Cell. Biochem. 448, 287-297.   DOI
8 Sun, Y., Zhang, H., Shi, J., Zhang, Z. and Gong, R. (2017) Identification of a novel inhibitor against Middle East respiratory syndrome coronavirus. Viruses 9, E255.
9 Wang, H., Li, X., Nakane, S., Liu, S., Ishikawa, H., Iwamoto, A. and Matsuda, Z. (2014) Co-expression of foreign proteins tethered to HIV-1 envelope glycoprotein on the cell surface by introducing an intervening second membrane-spanning domain. PLoS ONE 9, e96790.   DOI
10 Wang, C., Xia, S., Zhang, P., Zhang, T., Wang, W., Tian, Y., Meng, G., Jiang, S. and Liu, K. (2018) Discovery of hydrocarbon-stapled short alpha-helical peptides as promising Middle East respiratory syndrome coronavirus (MERS-CoV) fusion inhibitors. J. Med. Chem. 61, 2018-2026.   DOI
11 Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., Guo, D., Fu, L., Cui, Y., Liu, X., Arledge, K. C., Chen, Y. H., Zhang, L. and Wang, X. (2013) Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 23, 986-993.   DOI
12 Xia, S., Liu, Q., Wang, Q., Sun, Z., Su, S., Du, L., Ying, T., Lu, L. and Jiang, S. (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res. 194, 200-210.   DOI
13 Xu, W., Pu, J., Su, S., Hua, C., Su, X., Wang, Q., Jiang, S. and Lu, L. (2019) Revisiting the mechanism of enfuvirtide and designing an analog with improved fusion inhibitory activity by targeting triple sites in gp41. AIDS 33, 1545-1555.   DOI
14 Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J. I. and Matsuda, Z. (2016) Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrob. Agents Chemother. 60, 6532-6539.   DOI
15 Gao, J., Lu, G., Qi, J., Li, Y., Wu, Y., Deng, Y., Geng, H., Li, H., Wang, Q., Xiao, H., Tan, W., Yan, J. and Gao, G. F. (2013) Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J. Virol. 87, 13134-13140.   DOI
16 Bosch, B. J., van der Zee, R., de Haan, C. A. and Rottier, P. J. (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77, 8801-8811.   DOI
17 Chan, J. F., Lau, S. K., To, K. K., Cheng, V. C., Woo, P. C. and Yuen, K. Y. (2015) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 28, 465-522.   DOI
18 Cho, S. Y., Kang, J. M., Ha, Y. E., Park, G. E., Lee, J. Y., Ko, J. H., Lee, J. Y., Kim, J. M., Kang, C. I., Jo, I. J., Ryu, J. G., Choi, J. R., Kim, S., Huh, H. J., Ki, C. S., Kang, E. S., Peck, K. R., Dhong, H. J., Song, J. H., Chung, D. R. and Kim, Y. J. (2016) MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388, 994-1001.   DOI
19 Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P. and Shenkin, P. S. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739-1749.   DOI
20 Galasiti Kankanamalage, A. C., Kim, Y., Damalanka, V. C., Rathnayake, A. D., Fehr, A. R., Mehzabeen, N., Battaile, K. P., Lovell, S., Lushington, G. H., Perlman, S., Chang, K. O. and Groutas, W. C. (2018) Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. Eur. J. Med. Chem. 150, 334-346.   DOI
21 Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T. and Banks, J. L. (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750-1759.   DOI
22 Huang, X., Li, M., Xu, Y., Zhang, J., Meng, X., An, X., Sun, L., Guo, L., Shan, X., Ge, J., Chen, J., Luo, Y., Wu, H., Zhang, Y., Jiang, Q. and Ning, X. (2019) Novel gold nanorod-based HR1 peptide inhibitor for Middle East respiratory syndrome coronavirus. ACS Appl. Mater. Interfaces 11, 19799-19807.   DOI
23 Kandeel, M., Al-Taher, A., Li, H., Schwingenschlogl, U. and Al-Nazawi, M. (2018) Molecular dynamics of Middle East Respiratory Syndrome Coronavirus (MERS CoV) fusion heptad repeat trimers. Comput. Biol. Chem. 75, 205-212.   DOI
24 Kandeel, M., Altaher, A. and Alnazawi, M. (2019) Molecular dynamics and inhibition of MERS CoV papain-like protease by small molecule imidazole and aminopurine derivatives. Lett. Drug Des. Disc. 16, 584-591.   DOI
25 Kim, Y., Cheon, S., Min, C. K., Sohn, K. M., Kang, Y. J., Cha, Y. J., Kang, J. I., Han, S. K., Ha, N. Y., Kim, G., Aigerim, A., Shin, H. M., Choi, M. S., Kim, S., Cho, H. S., Kim, Y. S. and Cho, N. H. (2016) Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak. MBio 7, e00019.
26 Kirchmair, J., Distinto, S., Liedl, K. R., Markt, P., Rollinger, J. M., Schuster, D., Spitzer, G. M. and Wolber, G. (2011) Development of anti-viral agents using molecular modeling and virtual screening techniques. Inf. Disord. Drug Targets 11, 64-93.   DOI
27 Lee, H., Ren, J., Pesavento, R. P., Ojeda, I., Rice, A. J., Lv, H., Kwon, Y. and Johnson, M. E. (2019) Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling. Bioorg. Med. Chem. 27, 1981-1989.   DOI
28 Lu, L., Liu, Q., Zhu, Y., Chan, K. H., Qin, L., Li, Y., Wang, Q., Chan, J. F., Du, L., Yu, F., Ma, C., Ye, S., Yuen, K. Y., Zhang, R. and Jiang, S. (2014) Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 5, 3067.   DOI
29 Lundin, A., Bergström, T., Bendrioua, L., Kann, N., Adamiak, B. and Trybala, E. (2010) Two novel fusion inhibitors of human respiratory syncytial virus. Antiviral Res. 88, 317-324.   DOI
30 Kandeel, M., Elaiziz, M., Kandeel, A., Altaher, A. and Kitade, Y. (2014) Association of host tropism of Middle East syndrome coronavirus with the amino acid structure of host cell receptor dipeptidyl peptidase 4. Acta Virol. 58, 359-363.   DOI